Cancer BiologybioRxivPreprint
4-1BB is a target for immunotherapy in patients with undifferentiated pleomorphic sarcoma
Miriam J Melake, Henry G Smith, David Mansfield…·Martin McLaughlin
The paper identifies 4-1BB as a potential immunotherapy target in undifferentiated pleomorphic sarcoma by analyzing patient cohorts and TCGA data.
DOI 10.1101/2020.07.10.197293